Acompanhe as Notícias da Recifes

EV owners were sent hefty PCNs but say some signs in private car parks fail to warn of fees to park and recharge carDoes refuelling your car class as parking? The answer appears to be yes if it’s an electric vehicle. Guardian Money has been contacted by several readers who were fined after charging their cars away from home.The motorists report being caught out by signs that fail to make clear that charging points are subject to parking tariffs or to store opening times. Also, the

Donald Trump’s tariff threat recasts Brazil’s attempt to protect its democracy as unfair commercial practice – and gives Bolsonarism a Washington stageLast June, Brazil’s supreme court responded to the online lies that helped fuel Jair Bolsonaro’s failed far-right coup attempt in 2023. It ruled that social media platforms could be held liable for some users’ posts, forcing firms such as Elon Musk’s X and Mark Zuckerberg’s Meta to remove hate speech and anti-democratic content. A month

Recent strikes have sent oil prices climbing again, with average gas price per gallon up by 70 cents on last yearInflation cooled to an annual rate of 3.5% in June as the brief US-Iran ceasefire, which has since ended, brought energy prices down, according to new data from the Bureau of Labor Statistics.The consumer price index (CPI), which measures a basket of goods and services, has been elevated since the start of the war, largely because of higher energy prices. After mostly stayin

Newly minted rich and those anticipating huge IPOs are fueling buying and charter spree in the private jet sectorSign up for the Breaking News US newsletter email Aviation lawyer Amanda Applegate skipped her annual vacation last month as a surge of wealth from AI startups and SpaceX sent a wave of tech investors shopping for private jets, ⁠burying her in paperwork for aircraft-purchase agreements.The ⁠attorney, based in Cleveland, Ohio, attributed the rush to a handful ​of major “liqui

Brent crude dips slightly below $78 a barrel; most Asian stock markets bounce backBritain’s second-biggest drugmaker GSK has also taken a hit from recent drug failures.The Californian biotech Alector has said that GSK has ended their neuroscience collaboration covering ​two experimental antibody drugs, after both drug candidates suffered setbacks in clinical trials.The CARDIO-TTRansform trial was designed to examine the role of Wainua, a gene silencer treatment, on top of today’s stand